Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
GMS Journal for Medical Education|April 9, 2026
"Well advised" - Simulation of an ethical case consultation with students of evidence-based nursing, midwifery, and human medicine as part of an interprofessional education courseChristiane Vogel, Jan Schildmann, Sabine Sommerlatte, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 9, 2026
[Assisted suicide in Germany-initial analysis of data from a reporting platform and potential implications for the development of a guideline]Jan Schildmann, Thomas Pollmächer, Alfred Simon, et al.BMJ Public Health|December 3, 2025
How do financial considerations influence medical decision-making? A qualitative-empirical study in German cancer medicineJulia Felicitas Leni König, Birthe Aufenberg, Gereon Brei, et al.Journal of Cancer Research and Clinical Oncology|July 15, 2024
What does "urgency" mean when prioritizing cancer treatment? Results from a qualitative study with German oncologists and other experts during the COVID-19 pandemicSabine Sommerlatte, Helene Hense, Stephan Nadolny, et al.BMC Medical Ethics|May 7, 2026
Financial influences and the primacy of patient welfare - an empirical and ethical analysis in German cancer medicineJulia F L Koenig, Birthe Aufenberg, Gereon Brei, et al.BMC Palliative Care|August 5, 2026
Medical information and decision-making in palliative cancer: a qualitative study of patients' perceptions, needs, and preferences regarding physician communicationJulia Roick, Christian Heise, Nina Lambrecht, et al.Journal of Cancer Research and Clinical Oncology|January 26, 2023
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional surveySabine Sommerlatte, Celine Lugnier, Olaf Schoffer, et al.Clinical Colorectal Cancer|February 18, 2025
Significant Alterations of Colorectal Cancer Care in the COVID-19 Pandemic With High Adherence to Quality Criteria in German Cancer Centers (CC) ‒ Data From the AIO CancerCOVID Consortium (AIO-YMO/KRK 520/ass)Céline Lugnier, Sarah Förster, Sabine Sommerlatte, et al.Scientific Reports|September 28, 2020
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasisLucy Kappes, Ruba L Amer, Sabine Sommerlatte, et al.Oncology Research and Treatment|March 14, 2024
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in GermanyCeline Lugnier, Sabine Sommerlatte, Ulrike Attenberger, et al.Pageof 1